ATE322897T1 - Pyruvatesterzusammenstellung und verwendungsmethode zur wiederbelebung nach ischemie- und reperfusionsvorfällen - Google Patents
Pyruvatesterzusammenstellung und verwendungsmethode zur wiederbelebung nach ischemie- und reperfusionsvorfällenInfo
- Publication number
- ATE322897T1 ATE322897T1 AT00970657T AT00970657T ATE322897T1 AT E322897 T1 ATE322897 T1 AT E322897T1 AT 00970657 T AT00970657 T AT 00970657T AT 00970657 T AT00970657 T AT 00970657T AT E322897 T1 ATE322897 T1 AT E322897T1
- Authority
- AT
- Austria
- Prior art keywords
- composition
- ester
- acid esters
- organ
- physiological
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Inorganic Chemistry (AREA)
- Surgery (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15809199P | 1999-10-07 | 1999-10-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE322897T1 true ATE322897T1 (de) | 2006-04-15 |
Family
ID=22566643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00970657T ATE322897T1 (de) | 1999-10-07 | 2000-10-06 | Pyruvatesterzusammenstellung und verwendungsmethode zur wiederbelebung nach ischemie- und reperfusionsvorfällen |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1233767B1 (de) |
JP (1) | JP2003510357A (de) |
CN (1) | CN1377266A (de) |
AT (1) | ATE322897T1 (de) |
AU (1) | AU773407B2 (de) |
CA (1) | CA2386461A1 (de) |
DE (1) | DE60027319T2 (de) |
WO (1) | WO2001024793A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002074301A1 (en) * | 2001-03-15 | 2002-09-26 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions |
EP1494659B1 (de) * | 2002-04-17 | 2005-10-12 | Critical Therapeutics, Inc. | Pharmazeutische zusammensetzung enthaltend ein alpha-ketoalkansäureester oder -amid und milchsäure oder ein milchsäuresalz |
AU2003262830A1 (en) * | 2003-06-09 | 2005-01-28 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Method for treating acute pancreatitis |
US20050032891A1 (en) * | 2003-06-13 | 2005-02-10 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Method for treating alcoholic hepatitis |
EP1689431A4 (de) * | 2003-10-27 | 2010-11-17 | Univ Pennsylvania | Zytoprotektive wirkungen von ethylpyruvat |
EP1686979A4 (de) * | 2003-11-07 | 2010-03-03 | Jackson H M Found Military Med | Aktivierung von hypoxie-induzierbarer genexpression |
EP1924327A2 (de) | 2005-04-15 | 2008-05-28 | Biomac Privatinstitut für medizinische und Zahnmedizinische Forschung, Entwicklung und Diagnostik GmbH | Substanzen und pharmazeutische zusammensetzungen zur hemmung von glyoxalasen und ihre verwendung bei der bekämpfung von krebs |
WO2007120544A2 (en) * | 2006-04-12 | 2007-10-25 | Alexander Rayna L | Compositions comprising pyruvate alkyl esters and uses thereof |
GB201511207D0 (en) * | 2015-06-25 | 2015-08-12 | Xvivo Perfusion Ab | Isolated organ evaluation and treatment |
WO2017060422A1 (en) * | 2015-10-07 | 2017-04-13 | Neurovive Pharmaceutical Ab | Protected carboxylic acid-based metabolites for the treatment of mitochondrial disorders |
WO2017060418A1 (en) * | 2015-10-07 | 2017-04-13 | Neurovive Pharmaceutical Ab | Protected carboxylic acid-based metabolites for the treatment of mitochondria-related diseases |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5075210A (en) * | 1989-12-21 | 1991-12-24 | The Regents Of The University Of California | Preservation of the heart for transplantation |
WO1995011018A1 (en) * | 1991-11-27 | 1995-04-27 | University Of Pittsburgh Medical Center | Method for treating a medical patient for cardiac trauma |
US5876916A (en) * | 1996-03-18 | 1999-03-02 | Case Western Reserve University | Pyruvate compounds and methods for use thereof |
US6086789A (en) * | 1996-03-18 | 2000-07-11 | Case Western Reserve University | Medical uses of pyruvates |
-
2000
- 2000-10-06 EP EP00970657A patent/EP1233767B1/de not_active Expired - Lifetime
- 2000-10-06 DE DE60027319T patent/DE60027319T2/de not_active Expired - Fee Related
- 2000-10-06 CN CN00813879A patent/CN1377266A/zh active Pending
- 2000-10-06 WO PCT/US2000/027758 patent/WO2001024793A1/en active IP Right Grant
- 2000-10-06 JP JP2001527792A patent/JP2003510357A/ja active Pending
- 2000-10-06 AT AT00970657T patent/ATE322897T1/de not_active IP Right Cessation
- 2000-10-06 AU AU80005/00A patent/AU773407B2/en not_active Ceased
- 2000-10-06 CA CA002386461A patent/CA2386461A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU773407B2 (en) | 2004-05-27 |
AU8000500A (en) | 2001-05-10 |
EP1233767A4 (de) | 2005-02-09 |
CN1377266A (zh) | 2002-10-30 |
DE60027319D1 (de) | 2006-05-24 |
EP1233767A1 (de) | 2002-08-28 |
DE60027319T2 (de) | 2007-04-05 |
CA2386461A1 (en) | 2001-04-12 |
WO2001024793A1 (en) | 2001-04-12 |
JP2003510357A (ja) | 2003-03-18 |
EP1233767B1 (de) | 2006-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE322897T1 (de) | Pyruvatesterzusammenstellung und verwendungsmethode zur wiederbelebung nach ischemie- und reperfusionsvorfällen | |
JP7084320B2 (ja) | 生体直交型反応を用いた生体材料の代謝標識及び分子増強 | |
AUPR177300A0 (en) | Therapeutic methods | |
JP2015515960A (ja) | 局所非水性医薬製剤 | |
HK1041521A1 (en) | Growth differentiation factor inhibitors and uses therefor | |
WO2005035742A3 (en) | Methods of preparing and using stem cell compositions and kits comprising the same | |
UA73115C2 (en) | Use of dipeptidyl peptidase iv inhibitors for treating short stature due to growth hormone deficiency | |
MX2009003735A (es) | Composicion en deposito inyectable y su procedimiento de preparacion. | |
DE60012557D1 (de) | Hyaluronsäure enthaltende zusammensetzungen zur abgabe osteogener proteine | |
WO2003077835A3 (en) | Sodium dodecyl sulfate compositions for inactivating prions | |
DE60035574D1 (de) | Formulierungen zur behandlung von krankheiten und verfahren unter deren verwendung | |
US5719174A (en) | Indenoindole compounds for use in organ preservation | |
BR9907099A (pt) | Composições farmacêuticas | |
ATE260282T1 (de) | Aromatische ester von camptothecinen und verfahren zur behandlung von krebserkrankungen | |
GR3026602T3 (en) | Morphogen-induced liver regeneration. | |
US20160051581A1 (en) | Delivery of argon to a recipient of biological material | |
HUP0401687A2 (hu) | Szteroid-szulfatáz inhibitor acil-szulfonamidok és ezeket tartalmazó gyógyszerkészítmények | |
AU709318B2 (en) | Compositions that contain dialkyl (C1-C6)-ketone peroxide for preservation of organic tissues, and use of said compositions in the preservation and anatomical preparation of animal or human organic tissue | |
ATE465633T1 (de) | Verfahren zur preservierung von zellen, gewebe und organen | |
CO5160245A1 (es) | Compuestos organicos inhibidores de las proteinasas de cisteina, en particular inhibidores de catepsina k de arilaminoalquilamida, y su uso farmaceutico para el tratamiento o la profilaxis de enfermedades o condiciones medicas en donde este implicada | |
HUP9603489A2 (hu) | Gyógyszerkészítmény és eljárás előállítására | |
PL350450A1 (en) | Vitamin d analogues and their pharmaceutical use | |
WO2000057868A3 (en) | Use of carbamamic acid derivatives for the treatment of viral infections | |
RU2069016C1 (ru) | Способ моделирования дефицита ацетилхолина | |
EP1728857A3 (de) | Bereitstellung von Lebergewebe. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |